These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The mechanical stress-activated serum-, glucocorticoid-regulated kinase 1 contributes to neointima formation in vein grafts. Cheng J; Wang Y; Ma Y; Chan BT; Yang M; Liang A; Zhang L; Li H; Du J Circ Res; 2010 Nov; 107(10):1265-74. PubMed ID: 20884880 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological Targeting of Plasminogen Activator Inhibitor-1 Decreases Vascular Smooth Muscle Cell Migration and Neointima Formation. Ji Y; Weng Z; Fish P; Goyal N; Luo M; Myears SP; Strawn TL; Chandrasekar B; Wu J; Fay WP Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2167-2175. PubMed ID: 27659097 [TBL] [Abstract][Full Text] [Related]
8. The induction of yes-associated protein expression after arterial injury is crucial for smooth muscle phenotypic modulation and neointima formation. Wang X; Hu G; Gao X; Wang Y; Zhang W; Harmon EY; Zhi X; Xu Z; Lennartz MR; Barroso M; Trebak M; Chen C; Zhou J Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2662-9. PubMed ID: 22922963 [TBL] [Abstract][Full Text] [Related]
9. Kalirin promotes neointimal hyperplasia by activating Rac in smooth muscle cells. Wu JH; Fanaroff AC; Sharma KC; Smith LS; Brian L; Eipper BA; Mains RE; Freedman NJ; Zhang L Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):702-8. PubMed ID: 23288169 [TBL] [Abstract][Full Text] [Related]
10. Mixed-lineage kinase 3 deficiency promotes neointima formation through increased activation of the RhoA pathway in vascular smooth muscle cells. Gadang V; Konaniah E; Hui DY; Jaeschke A Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1429-36. PubMed ID: 24790140 [TBL] [Abstract][Full Text] [Related]
11. Activation of NAD(P)H:quinone oxidoreductase 1 prevents arterial restenosis by suppressing vascular smooth muscle cell proliferation. Kim SY; Jeoung NH; Oh CJ; Choi YK; Lee HJ; Kim HJ; Kim JY; Hwang JH; Tadi S; Yim YH; Lee KU; Park KG; Huh S; Min KN; Jeong KH; Park MG; Kwak TH; Kweon GR; Inukai K; Shong M; Lee IK Circ Res; 2009 Apr; 104(7):842-50. PubMed ID: 19229058 [TBL] [Abstract][Full Text] [Related]
12. Inactivation of the tumour suppressor, PTEN, in smooth muscle promotes a pro-inflammatory phenotype and enhances neointima formation. Furgeson SB; Simpson PA; Park I; Vanputten V; Horita H; Kontos CD; Nemenoff RA; Weiser-Evans MC Cardiovasc Res; 2010 May; 86(2):274-82. PubMed ID: 20051384 [TBL] [Abstract][Full Text] [Related]
13. Adenosine monophosphate-activated protein kinase-α2 deficiency promotes vascular smooth muscle cell migration via S-phase kinase-associated protein 2 upregulation and E-cadherin downregulation. Song P; Zhou Y; Coughlan KA; Dai X; Xu H; Viollet B; Zou MH Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2800-9. PubMed ID: 24115035 [TBL] [Abstract][Full Text] [Related]
14. Uncoupling Protein 2 Inhibits Myointimal Hyperplasia in Preclinical Animal Models of Vascular Injury. Zhang Y; Zhang Y; Li W; Wang P; Gu R; Feng Y; Wei S; Peng K; Zhang Y; Su L; Wang Q; Li D; Yang D; Wong WT; Yang Y; Ma S J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29025747 [TBL] [Abstract][Full Text] [Related]
15. The role of vascular smooth muscle cell membrane-bound thrombomodulin in neointima formation. Wang KC; Chen PS; Chao TH; Luo CY; Chung HC; Tseng SY; Huang TY; Lin YL; Shi GY; Wu HL; Li YH Atherosclerosis; 2019 Aug; 287():54-63. PubMed ID: 31212235 [TBL] [Abstract][Full Text] [Related]
16. N-oleoylethanolamide suppresses intimal hyperplasia after balloon injury in rats through AMPK/PPARα pathway. Zhao Y; Liu Y; Jing Z; Peng L; Jin P; Lin Y; Zhou Y; Yang L; Ren J; Xie Q; Jin X Biochem Biophys Res Commun; 2018 Feb; 496(2):415-421. PubMed ID: 29305859 [TBL] [Abstract][Full Text] [Related]